While Ivermectin 12mg has been approved by regulatory authorities for certain parasitic infections, such as onchocerciasis (river blindness) and strongyloidiasis, it is essential to emphasize that its off-label use for other conditions, including viral infections such as COVID-19, is not universally accepted or supported by the medical community.